Anti-FAM200A monoclonal antibody

Pre-made anti-FAM200A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to FAM200A/FAM200A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0813-Ab-1/ GM-Tg-hg-IP0813-Ab-2Anti-Human FAM200A monoclonal antibodyHuman
GM-Tg-rg-IP0813-Ab-1/ GM-Tg-rg-IP0813-Ab-2Anti-Rat FAM200A monoclonal antibodyRat
GM-Tg-mg-IP0813-Ab-1/ GM-Tg-mg-IP0813-Ab-2Anti-Mouse FAM200A monoclonal antibodyMouse
GM-Tg-cynog-IP0813-Ab-1/ GM-Tg-cynog-IP0813-Ab-2Anti-Cynomolgus/ Rhesus macaque FAM200A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0813-Ab-1/ GM-Tg-felg-IP0813-Ab-2Anti-Feline FAM200A monoclonal antibodyFeline
GM-Tg-cang-IP0813-Ab-1/ GM-Tg-cang-IP0813-Ab-2Anti-Canine FAM200A monoclonal antibodyCanine
GM-Tg-bovg-IP0813-Ab-1/ GM-Tg-bovg-IP0813-Ab-2Anti-Bovine FAM200A monoclonal antibodyBovine
GM-Tg-equg-IP0813-Ab-1/ GM-Tg-equg-IP0813-Ab-2Anti-Equine FAM200A monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0813-Ab-1/ GM-Tg-hg-IP0813-Ab-2; GM-Tg-rg-IP0813-Ab-1/ GM-Tg-rg-IP0813-Ab-2;
GM-Tg-mg-IP0813-Ab-1/ GM-Tg-mg-IP0813-Ab-2; GM-Tg-cynog-IP0813-Ab-1/ GM-Tg-cynog-IP0813-Ab-2;
GM-Tg-felg-IP0813-Ab-1/ GM-Tg-felg-IP0813-Ab-2; GM-Tg-cang-IP0813-Ab-1/ GM-Tg-cang-IP0813-Ab-2;
GM-Tg-bovg-IP0813-Ab-1/ GM-Tg-bovg-IP0813-Ab-2; GM-Tg-equg-IP0813-Ab-1/ GM-Tg-equg-IP0813-Ab-2
Products NameAnti-FAM200A monoclonal antibody
Formatmab
Target NameFAM200A
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-FAM200A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0813-Ag-1Recombinant multi-species F200A/ FAM200A/ C7orf38 protein


    Target information

    Target IDGM-IP0813
    Target NameFAM200A
    Gene ID221786,718782,101904760,100147118
    Gene Symbol and SynonymsC7orf38,FAM200A
    Uniprot AccessionQ8TCP9
    Uniprot Entry NameF200A_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000221909
    Target ClassificationN/A

    The target: FAM200A, gene name: FAM200A, also named as C7orf38. This gene encodes a protein of unknown function. The protein is weakly similar to transposase-like proteins in human and mouse. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.